Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2

2(33.3%)

Phase 4

2(33.3%)

Phase 3

1(16.7%)

N/A

1(16.7%)

6Total

Phase 2(2)

Phase 4(2)

Phase 3(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07263607Phase 2Not Yet Recruiting

A Multicenter Clinical Trial Evaluating the Efficacy and Safety of Taurine as an Adjunctive Therapy in Multiple Sclerosis

Role: collaborator

NCT06874673Not ApplicableNot Yet Recruiting

Pronase in Improving Endoscopic Mucosal Clarity During Colonoscopy for Patients with Colitis

Role: collaborator

NCT06501651Phase 4Not Yet Recruiting

Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy

Role: collaborator

NCT04370925Phase 3Recruiting

Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis

Role: collaborator

NCT03516266Unknown

A Cross-sectional Study of Female Pelvic Floor Muscle Function in Chinese Healthy Female

Role: collaborator

NCT03506204Unknown

The Pelvic Floor Muscle Function in Chinese Primipara, a One-year Cohort Study

Role: collaborator

NCT03393507Phase 2Unknown

A Study of Apatinib Treatment in for Advanced Ovarian Cancer

Role: lead

NCT00548223Phase 4Completed

The Secondary Prevention Trial for Ischemic Stroke With DengzhanShengmai Capsule

Role: collaborator

All 8 trials loaded